SEC Form 4 · accession 0001193125-26-340528
Braveheart Bio, Inc. · BRVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Forbion Growth III Management B.V.
10% Owner
Forbion Ventures VII Management B.V.
10% Owner
Period of report
Aug 7, 2026
Accepted (ET)
Aug 7, 2026 · 5:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002131524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 7, 2026 | C | 9,132,420 | $0.00 | A | 9,720,546 | D | |
| Common StockF3 | Aug 7, 2026 | C | 7,990,867 | $0.00 | A | 8,505,478 | I | By Forbion Ventures Fund VII Cooperatief U.A. |
| Common StockF2 | Aug 7, 2026 | P | 1,920,000 | $18.00 | A | 11,640,546 | D | |
| Common StockF3 | Aug 7, 2026 | P | 1,680,000 | $18.00 | A | 10,185,478 | I | By Forbion Ventures Fund VII Cooperatief U.A. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Preferred StockF2,F1 | — | Aug 7, 2026 | C | 40,000,000 | D | — | — | Common Stock | 9,132,420 | 0 | D |
| Series A Preferred StockF3,F1 | — | Aug 7, 2026 | C | 35,000,000 | D | — | — | Common Stock | 7,990,867 | 0 | I |
Explanation of responses
- F1Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock automatically converted into Common Stock on a one-for-4.38 basis without payment of consideration. The Series A Preferred Stock had no expiration date.
- F2Forbion Growth III Management B.V. ("Forbion Growth III Management") is the director of Forbion Growth Opportunities Fund III Cooperatief U.A. (the "Forbion Growth III") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Growth III. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.
- F3Forbion Ventures VII Management B.V. ("Forbion VII Director") is the director of Forbion Ventures Fund VII Cooperatief U.A. (the "Forbion Ventures VII") and may be deemed to have voting and dispositive power over the securities beneficially owned by the Forbion Ventures VII. Each of the Reporting Persons disclaims Section 16 beneficial ownership of such shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any of the Reporting Persons are the beneficial owner of such shares for Section 16 or any other purpose.